Cargando…
C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome
Background: Cardiovascular disease (CVD) is the primary cause of premature death and disability worldwide. There is extensive evidence that inflammation represents an important pathogenetic mechanism in the development and prognosis of CVD. C-reactive protein (CRP) is a potential marker of vascular...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341152/ https://www.ncbi.nlm.nih.gov/pubmed/37443809 http://dx.doi.org/10.3390/cells12131775 |
_version_ | 1785072194265546752 |
---|---|
author | Schulz, Susanne Rehm, Selina Schlitt, Axel Lierath, Madlen Lüdike, Henriette Hofmann, Britt Bitter, Kerstin Reichert, Stefan |
author_facet | Schulz, Susanne Rehm, Selina Schlitt, Axel Lierath, Madlen Lüdike, Henriette Hofmann, Britt Bitter, Kerstin Reichert, Stefan |
author_sort | Schulz, Susanne |
collection | PubMed |
description | Background: Cardiovascular disease (CVD) is the primary cause of premature death and disability worldwide. There is extensive evidence that inflammation represents an important pathogenetic mechanism in the development and prognosis of CVD. C-reactive protein (CRP) is a potential marker of vascular inflammation and plays a direct role in CVD by promoting vascular inflammation. The objective of this study (ClinTrials.gov identifier: NCT01045070) was to assess the prognostic impact of CRP protein levels and genetic variants of CRP gene events on cardiovascular (CV) outcome (10-year follow-up) in patients suffering from CVD. Methods: CVD patients were prospectively included in this study (n = 1002) and followed up (10 years) regarding combined CV endpoint (CV death, death from stroke, myocardial infarction (MI), and stroke/transient ischemic attack (TIA)). CRP protein level (particle-enhanced immunological turbidity test) and genetic variants (rs1130864, rs1417938, rs1800947, rs3093077; polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) after DNA extraction from EDTA-blood) were evaluated. Results: In survival analyses, increased CRP protein levels of ≥5 mg/L (log-rank test: p < 0.001, Cox regression: p = 0.002, hazard ratio = 1.49) and CT + TT genotype of rs1130864 (log-rank test: p = 0.041; Cox regression: p = 0.103, hazard ratio = 1.21) were associated with a weaker CV prognosis considering combined CV endpoint. Conclusions: Elevated CRP level and genetic variant (rs1130864) were proven to provide prognostic value for adverse outcome in CVD patients within the 10-year follow-up period. |
format | Online Article Text |
id | pubmed-10341152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103411522023-07-14 C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome Schulz, Susanne Rehm, Selina Schlitt, Axel Lierath, Madlen Lüdike, Henriette Hofmann, Britt Bitter, Kerstin Reichert, Stefan Cells Article Background: Cardiovascular disease (CVD) is the primary cause of premature death and disability worldwide. There is extensive evidence that inflammation represents an important pathogenetic mechanism in the development and prognosis of CVD. C-reactive protein (CRP) is a potential marker of vascular inflammation and plays a direct role in CVD by promoting vascular inflammation. The objective of this study (ClinTrials.gov identifier: NCT01045070) was to assess the prognostic impact of CRP protein levels and genetic variants of CRP gene events on cardiovascular (CV) outcome (10-year follow-up) in patients suffering from CVD. Methods: CVD patients were prospectively included in this study (n = 1002) and followed up (10 years) regarding combined CV endpoint (CV death, death from stroke, myocardial infarction (MI), and stroke/transient ischemic attack (TIA)). CRP protein level (particle-enhanced immunological turbidity test) and genetic variants (rs1130864, rs1417938, rs1800947, rs3093077; polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) after DNA extraction from EDTA-blood) were evaluated. Results: In survival analyses, increased CRP protein levels of ≥5 mg/L (log-rank test: p < 0.001, Cox regression: p = 0.002, hazard ratio = 1.49) and CT + TT genotype of rs1130864 (log-rank test: p = 0.041; Cox regression: p = 0.103, hazard ratio = 1.21) were associated with a weaker CV prognosis considering combined CV endpoint. Conclusions: Elevated CRP level and genetic variant (rs1130864) were proven to provide prognostic value for adverse outcome in CVD patients within the 10-year follow-up period. MDPI 2023-07-04 /pmc/articles/PMC10341152/ /pubmed/37443809 http://dx.doi.org/10.3390/cells12131775 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schulz, Susanne Rehm, Selina Schlitt, Axel Lierath, Madlen Lüdike, Henriette Hofmann, Britt Bitter, Kerstin Reichert, Stefan C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome |
title | C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome |
title_full | C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome |
title_fullStr | C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome |
title_full_unstemmed | C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome |
title_short | C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome |
title_sort | c-reactive protein level and the genetic variant rs1130864 in the crp gene as prognostic factors for 10-year cardiovascular outcome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341152/ https://www.ncbi.nlm.nih.gov/pubmed/37443809 http://dx.doi.org/10.3390/cells12131775 |
work_keys_str_mv | AT schulzsusanne creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome AT rehmselina creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome AT schlittaxel creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome AT lierathmadlen creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome AT ludikehenriette creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome AT hofmannbritt creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome AT bitterkerstin creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome AT reichertstefan creactiveproteinlevelandthegeneticvariantrs1130864inthecrpgeneasprognosticfactorsfor10yearcardiovascularoutcome |